CAD tools help compare prior and current mammograms
The computer-aided detection firm R2 Technology has teamed with Swedish workstation leader Sectra to produce a “CAD-intelligent” system that optimizes the presentation of CAD information on mammographic images. The companies jointly launched the Citra mammography applications suite at the RSNA meeting.
The computer-aided detection firm R2 Technology has teamed with Swedish workstation leader Sectra to produce a "CAD-intelligent" system that optimizes the presentation of CAD information on mammographic images. The companies jointly launched the Citra mammography applications suite at the RSNA meeting.
Citra includes software tools such as RightSize Optimized Temporal Comparison, which automatically and optimally scales mammograms to the display window, sizing the previous mammogram with the current image. It can scale images obtained from full-field digital mammography systems that have different detector sizes and acquisition resolutions, compare prior digitized films using R2's DigitalNow software with current digital mammography images, and reconcile two sets of images that were acquired with different compression paddles.
RightSize and other software products in the Citra release have been designed to work with the Sectra IDS5/mx.net multimodality breast imaging workstation and PACS, as well as the R2 ImageChecker mammography CAD system. The package of software applications is also compatible with full-field digital mammography systems approved by the FDA, including those from GE Healthcare, Hologic, and Siemens Medical Solutions.
Citra is currently available only on the Sectra workstation. Over time, however, the components will migrate to other workstations, according to the company.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
